PAIN
Volume 146, Issue 1 , Pages 199-204 , November 2009

Intrathecal glycine for pain and dystonia in complex regional pain syndrome

  • Alexander G. Munts

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • Anton A. van der Plas

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • Joan H. Voormolen

      Affiliations

    • Department of Neurosurgery, Leiden University Medical Center, The Netherlands
    • ,
  • Johan Marinus

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • Irene M. Teepe-Twiss

      Affiliations

    • Department of Pharmacy, Leiden University Medical Center, The Netherlands
    • ,
  • Willem Onkenhout

      Affiliations

    • Department of Clinical Chemistry, Leiden University Medical Center, The Netherlands
    • ,
  • Joop M. van Gerven

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Centre for Human Drug Research, Zernikedreef 10, 2333 CL Leiden, The Netherlands
    • ,
  • Jacobus J. van Hilten

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Neurology, Leiden University Medical Center, P.O. Box 9600, Albinusdreef 2, 2300 RC Leiden, The Netherlands. Tel.: +31 71 5262134; fax: +31 71 5248253.

Received 9 February 2009 ,Revised 19 July 2009 ,Accepted 23 July 2009.

References 

  1. Ahmadi S, Muth-Selbach U, Lauterbach A, Lipfert P, Neuhuber WL, Zeilhofer HU. Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science. 2003;300:2094–2097
  2. Avanzino L, Martino D, van de Warrenburg BP, Schneider SA, Abbruzzese G, Defazio G, et al. Cortical excitability is abnormal in patients with the “fixed dystonia” syndrome. Mov Disord. 2008;23:646–652
  3. Bakker MJ, van Dijk JG, van den Maagdenberg AM, Tijssen MA. Startle syndromes. Lancet Neurol. 2006;5:513–524
  4. Beyer C, Komisaruk BR, Lopez-Colome AM, Caba M. Administration of AP5, a glutamate antagonist, unmasks glycine analgesic actions in the rat. Pharmacol Biochem Behav. 1992;42:229–232
  5. Bhatia KP, Bhatt MH, Marsden CD. The causalgia-dystonia syndrome. Brain. 1993;116:843–851
  6. Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437:199–202
  7. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184
  8. Breitinger HG, Becker CM. The inhibitory glycine receptor-simple views of a complicated channel. Chembiochem. 2002;3:1042–1052
  9. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985;35:73–77
  10. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002;415:793–798
  11. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263–275
  12. D’Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, et al. IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry. 2000;47:450–462
  13. Eisenberg E, Chistyakov AV, Yudashkin M, Kaplan B, Hafner H, Feinsod M. Evidence for cortical hyperexcitability of the affected limb representation area in CRPS: a psychophysical and transcranial magnetic stimulation study. Pain. 2005;113:99–105
  14. Eulenburg V, Armsen W, Betz H, Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci. 2005;30:325–333
  15. Ferguson AR, Crown ED, Grau JW. Nociceptive plasticity inhibits adaptive learning in the spinal cord. Neuroscience. 2006;141:421–431
  16. Floeter MK, Gerloff C, Kouri J, Hallett M. Cutaneous withdrawal reflexes of the upper extremity. Muscle Nerve. 1998;21:591–598
  17. Florea I, Popa M, Simionescu L, Dinulescu E, Juvina E. Clinical use of glycine intravenous load for diagnosis of growth hormone deficiency. Clin Endocrinol (Oxf). 1976;5:283–286
  18. Frucht SJ, Leurgans SE, Hallett M, Fahn S. The unified myoclonus rating scale. Adv Neurol. 2002;89:361–376
  19. Harvey RJ, Depner UB, Wässle H, Ahmadi S, Heindl C, Reinold H, et al. GlyR α3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science. 2004;304:884–887
  20. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, Huygen FJ, van der Meijden P, Hop WC, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm. 2006;2006:28398
  21. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 1999;56:29–36
  22. Huang W, Simpson RK. Long-term intrathecal administration of glycine prevents mechanical hyperalgesia in a rat model of neuropathic pain. Neurol Res. 2000;22:160–164
  23. Huygen FJ, de Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  24. Jänig W, Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurol. 2003;2:687–697
  25. Jankovic J, Lang AE. Movement disorders: diagnosis and assessment. In:  Bradley WG,  Daroff RB,  Fenichel GM,  Jankovic J editor. Neurology in clinical practice. Principles of diagnosis and management. vol. 1:Philadelphia: Butterworth Heinemann; 2004;p. 305–306
  26. Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, et al. Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol. 2001;4:385–391
  27. Larson MD. Glycine and the blood–brain barrier. Anesthesiology. 1983;58:488–489
  28. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197–204
  29. Libenson MH, Yang JM. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2001. A 16-year-old boy with an altered mental status and muscle rigidity. N Engl J Med. 2001;344:1232–1239
  30. Maihöfner C, Baron R, DeCol R, Binder A, Birklein F, Deuschl G, et al. The motor system shows adaptive changes in complex regional pain syndrome. Brain. 2007;130:2671–2687
  31. Marx J. Neuroscience. Locating a new step in pain’s pathway. Science. 2004;304:811
  32. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299
  33. Merens W, Booij L, Markus R, Zitman FG, Onkenhout W, van der Does AJ. The effects of a diet enriched with alpha-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br J Nutr. 2005;94:415–422
  34. Merskey H, Bogduk N. Relatively generalized syndromes. In:  Merskey H,  Bogduk N editor. Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994;p. 40–43
  35. Müller F, Heinke B, Sandkühler J. Reduction of glycine receptor-mediated miniature inhibitory postsynaptic currents in rat spinal lamina I neurons after peripheral inflammation. Neuroscience. 2003;122:799–805
  36. Oerlemans HM, Cup EH, DeBoo T, Goris RJ, Oostendorp RA. The Radboud skills questionnaire: construction and reliability in patients with reflex sympathetic dystrophy of one upper extremity. Disabil Rehabil. 2000;22:233–245
  37. Perez RS, Roorda LD, Zuurmond WW, Bannink II, Vranken JH, de Lange JJ. Measuring perceived activity limitations in lower extremity complex regional pain syndrome type 1 (CRPS I): test–retest reliability of two questionnaires. Clin Rehabil. 2002;16:454–460
  38. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-d-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108–1116
  39. Pollay M. Movement of glycine across the blood–brain barrier of the rabbit. J Neurobiol. 1976;7:123–128
  40. Rommel O, Malin JP, Zenz M, Jänig W. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain. 2001;93:279–293
  41. Saito K, Konishi S, Otsuka M. Antagonism between Lioresal and substance P in rat spinal cord. Brain Res. 1975;97:177–180
  42. Schwartzman RJ, Kerrigan J. The movement disorder of reflex sympathetic dystrophy. Neurology. 1990;40:57–61
  43. Schwenkreis P, Janssen F, Rommel O, Pleger B, Völker B, Hosbach I, et al. Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology. 2003;61:515–519
  44. Simpson RK, Gondo M, Robertson CS, Goodman JC. Reduction in the mechanonociceptive response by intrathecal administration of glycine and related compounds. Neurochem Res. 1996;21:1221–1226
  45. Simpson RK, Gondo M, Robertson CS, Goodman JC. Reduction in thermal hyperalgesia by intrathecal administration of glycine and related compounds. Neurochem Res. 1997;22:75–79
  46. Sinis N, Birbaumer N, Gustin S, Schwarz A, Bredanger S, Becker ST, et al. Memantine treatment of complex regional pain syndrome: a preliminary report of six cases. Clin J Pain. 2007;23:237–243
  47. Ushida T, Tani T, Kanbara T, Zinchuk VS, Kawasaki M, Yamamoto H. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med. 2002;27:524–528
  48. van de Beek WJ, Vein A, Hilgevoord AA, van Dijk JG, van Hilten BJ. Neurophysiologic aspects of patients with generalized or multifocal tonic dystonia of reflex sympathetic dystrophy. J Clin Neurophysiol. 2002;19:77–83
  49. van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med. 2000;343:625–630
  50. van Hilten JJ, Blumberg H, Schwartzman RJ. Factor IV: movement disorders and dystrophy – pathophysiology and measurement. In:  Wilson P,  Stanton-Hicks M,  Harden RN editor. CRPS: current diagnosis and therapy, progress in pain research and management. vol. 32:Seattle: IASP Press; 2005;p. 119–137
  51. van Rijn M, Munts AG, Marinus J, Voormolen JH, de Boer KS, Teepe-Twiss IM, et al. Intrathecal baclofen for dystonia of complex regional pain syndrome. Pain. 2009;143:41–47
  52. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–607
  53. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012–1016
  54. Vranken JH, Troost D, Wegener JT, Kruis MR, van der Vegt MH. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain. Pain. 2005;117:231–235
  55. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–1964
  56. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–1769
  57. Yaksh TL, Allen JW. Preclinical insights into the implementation of intrathecal midazolam: a cautionary tale. Anesth Analg. 2004;98:1509–1511
  58. Yaksh TL, Allen JW. The use of intrathecal midazolam in humans: a case study of process. Anesth Analg. 2004;98:1536–1545
  59. Zuniga RE, Perera S, Abram SE. Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome. Reg Anesth Pain Med. 2002;27:90–93

PII: S0304-3959(09)00416-3

doi: 10.1016/j.pain.2009.07.030

PAIN
Volume 146, Issue 1 , Pages 199-204 , November 2009

Article Tools